SWEEP: Shuttle Walking Test for Exercise Evaluation in Pulmonary Resection
NCT ID: NCT07102589
Last Updated: 2025-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2025-06-01
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Currently, tools such as DLCO or cardiopulmonary exercise testing (CPET) are used to assess surgical risk and exercise capacity before lung surgery. However, these tests are not always accessible due to equipment limitations or long waiting times. The SWT is a simpler, safer, and more cost-effective alternative that has been recently recognized as a new medical technology in Korea for evaluating exercise capacity.
In this study, patients with chronic lung diseases (such as COPD, ILD, or bronchiectasis) who are scheduled to undergo lung resection will perform the SWT before surgery. Their symptoms and quality of life will be assessed through questionnaires before and three months after the surgery. The goal is to determine whether SWT results can help predict postoperative dyspnea and provide useful information for preoperative risk stratification.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Study for the Reliability and Validity of Incremental Shuttle Walking Test for COPD Patients in Korea
NCT04178278
The Impacts of Pulmonary Rehabilitation Therapy on Patients After Thoracic Surgery
NCT02757092
Pulmonary Rehab, Dyspnea, Walk and Step Testing in COPD
NCT02542826
Validation of an Intermittent Shuttle Walking Protocol in Patients With COPD
NCT04326855
Interest of Performing Two 6-minute Walk Tests at the End of a Pulmonary Rehabilitation Program, in COPD Patients.
NCT05850299
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for surgical lung resection (e.g., for lung cancer or benign tumor)
* Diagnosis of chronic respiratory disease (COPD, ILD, or bronchiectasis)
* Able to perform Shuttle Walking Test (ISWT + ESWT) before surgery
* Able to complete pre- and postoperative symptom questionnaires (dyspnea, EQ-5D)
Exclusion Criteria
* Inability to communicate in Korean
* Decline or withdraw consent
* Severe lower limb disability interfering with walking (e.g., fracture, paralysis)
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, Not Required For This Country, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-2506-980-301
Identifier Type: REGISTRY
Identifier Source: secondary_id
SWEEP-PRO-SNUBH-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.